3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
10
Stomach Neoplasms
8
Neoplasm Metastasis
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Nasopharyngeal Carcinoma
5
Leukemia, Myeloid, Acute
5
Esophageal Neoplasms
5
Small Cell Lung Carcinoma
4
Pancreatic Neoplasms
4
Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Endometrial Neoplasms
3
Adenocarcinoma Of Esophagus
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Mouth Neoplasms
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Carcinoma, Squamous Cell
2
Anatomic Stage II Breast Cancer AJCC v8
2
Advanced Solid Tumors
2
Unresectable Locally Recurrent Rectal Cancer
1
Thymoma
1
Interventions
X-Rays
9
Specimen Handling
8
Phantoms, Imaging
8
Magnetic Resonance Spectroscopy
8
Vincristine
5
Nuclear Medicine Department, Hospital
5
Biopsy
5
Doxorubicin
4
Etoposide
3
Dactinomycin
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Temozolomide
2
Radiotherapy, Conformal
2
Radiotherapy
2
Radiation
2
LY3023414
2
Irinotecan
2
talazoparib
1
selinexor
1
pembrolizumab
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Drug Therapy
×
90 days
×
Clear all
No trials found.